Boehringer Ingelheim - Expert Perspectives in Navigating the Evolving Treatment Landscape in Advanced NSCLC
A Strategic Approach to Select and Sequence Therapies in EGFRM+ NSCLC: Asia in Focus
Date
19 Nov 2021Session
Boehringer Ingelheim - Expert Perspectives in Navigating the Evolving Treatment Landscape in Advanced NSCLCPresenters
Caicun ZhouAuthors
C. ZhouAuthor affiliations
- Department Of Medical Oncology, Shanghai Pulmonary Hospital - Tongji University School of Medicine, 200433 - Shanghai/CN
Resources
Resources from the same session
Opening and welcome remarks
Presenter: Darren Wan-Teck Lim
Session: Boehringer Ingelheim - Expert Perspectives in Navigating the Evolving Treatment Landscape in Advanced NSCLC
Resources:
Webcast
Tackling Uncommon EGFR Mutations
Presenter: Satoru Miura
Session: Boehringer Ingelheim - Expert Perspectives in Navigating the Evolving Treatment Landscape in Advanced NSCLC
Resources:
Webcast
The Role of EGFR-TKIs in the Treatment of Squamous NSCLC
Presenter: Chung-Yu Chen
Session: Boehringer Ingelheim - Expert Perspectives in Navigating the Evolving Treatment Landscape in Advanced NSCLC
Resources:
Webcast
LIVE Q&A
Presenter: Darren Wan-Teck Lim
Session: Boehringer Ingelheim - Expert Perspectives in Navigating the Evolving Treatment Landscape in Advanced NSCLC
Resources:
Webcast